As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
1, Traditional small molecule drugs
(1)Tissue penetration: Usually very good;
(2)Binding: Usually contains distributions;
(3)Degradation: Metabolic degradation;
(4)Renal elimination: Usually very important;
(5)Free concentration: Thought to play a role in small molecule drug activity;
(6)Pharmacokinetics: Typically, linear; usually independent of pharmacodynamics.
2, Monoclonal antibody
(1)Tissue penetration: Usually weak;
(2)Binding: Usually involves clearance;
(3)Degradation: Hydrolytic degradation of proteins;
(4)Renal elimination: Rare;
(5)Free concentration: Thought to contribute to function and immunogenicity;
(6)Pharmacokinetics: Typically, nonlinear: usually dependent on pharmacodynamics and half-life of antigen x antibody (HAxA).